Prevalence of angiotensin II Type 1 receptor antibodies in persons with hypertension and relation to blood pressure and medication

Mary Carmelle Philogene, Dingfen Han, Flor Alvarado, Neal S. Fedarko, Alan B. Zonderman, Michele K. Evans, Deidra C. Crews

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


BACKGROUND: We aimed to determine the prevalence of antibodies against angiotensin II type 1 receptor (AT1RAb) in hypertensive adults and elucidate the relation of antihypertensive medication type to blood pressure (BP) among persons with and without AT1RAb. METHODS: Sera from participants in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study with hypertension were tested for AT1RAb using a commercial Enzyme-linked immunosorbent assay (ELISA) (One Lambda; positive ≥17 units/ml). BP measurements, uncontrolled BP (systolic BP ≥140 and/or diastolic BP ≥90 mm Hg), and effect of BP medication type were compared for AT1RAb positive (+) vs. negative (−) participants using descriptive statistics and multivariable regression. RESULTS: One hundred and thirty-two (13.1%) participants were AT1RAb+. Compared with AT1RAb−, AT1RAb+ persons were more likely to be white (47% vs. 36.7%; P = 0.03) but had similar comorbid disease burden. In models adjusting for age, sex, and race, AT1RAb+ persons had higher diastolic BP (β = 2.61 mm Hg; SE = 1.03; P = 0.01) compared with AT1RAb− participants. Rates of uncontrolled BP were similar between the groups. AT1RAb+ persons on an angiotensin receptor blocker (ARB; n = 21) had a mean of 10.5 mm Hg higher systolic BP (SE = 4.56; P = 0.02) compared with AT1RAb+ persons using other BP medications. The odds of uncontrolled BP among AT1RAb+ participants on an ARB was 2.05 times that of those on other medications. AT1RAb− persons prescribed an angiotensin-converting enzyme inhibitor (ACEi) had 1.8 mm Hg lower diastolic BP (SE = 0.81; P = 0.03) than AT1RAb− persons not prescribed an ACEi. CONCLUSIONS: AT1RAb was prevalent among hypertensive adults and was associated with higher BP among persons on an ARB.

Original languageEnglish (US)
Pages (from-to)734-740
Number of pages7
JournalAmerican Journal of Hypertension
Issue number8
StatePublished - Aug 1 2020


  • Angiotensin II type 1 receptor antibody
  • Blood pressure
  • Health disparities
  • Hypertension

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Prevalence of angiotensin II Type 1 receptor antibodies in persons with hypertension and relation to blood pressure and medication'. Together they form a unique fingerprint.

Cite this